Business · 06/07/2026Updated: 10/17/2026 · 1 min read

FDA Clears Vasopressin for Sale After Review

The FDA has determined that vasopressin 0.9% injection, 50 units/50 mL, was not withdrawn from sale due to safety or effectiveness concerns, paving the way for potential approval of abbreviated new drug applications.